The UK pneumococcal conjugate vaccine (PCV) immunisation programme has successfully achieved high levels of population (herd) protection for all age groups.

Currently, circulation of the 13 pneumococcal serotypes contained in the vaccine, and therefore, the risk of disease due to these serotypes, even in those at higher risk, is very low in the UK.

The PCV13 immunisation schedule has therefore been changed as follows:

The one-year booster dose should be given regardless of the number of doses given under one year of age.